Sun Pharma Q4 profit rises 26% YoY to ₹2,714 crore
pre-market1 source ↓written by the desknot a recommendation
- from ₹2
- 26% YoY
- in Q4FY26
- 13% to ₹14,612 cr
- from ₹3
- 19% sequentially
Sun Pharmaceuticals reported a consolidated net profit of ₹2,714 cr, up 26% YoY from ₹2,150 cr. Revenue increased 13% to ₹14,612 cr in Q4FY26. However, profit fell 19% sequentially from ₹3,369 cr in Q3FY26. The board approved a final dividend of ₹5 per share, pending AGM approval.
Not investment advice. For informational purposes only.